期刊
FASEB JOURNAL
卷 35, 期 6, 页码 -出版社
WILEY
DOI: 10.1096/fj.202100054RR
关键词
cancer; collagen; extracellular matrix; invasion
资金
- Natural Science Foundation of Jilin Province [20180101158JC]
COL11A1 is upregulated in various cancers and is associated with tumor progression, poor prognosis, angiogenesis, invasion, and drug resistance. While the specific mechanism by which COL11A1 regulates tumor progression remains unclear, it shows potential as a target for cancer treatment.
Extracellular matrix (ECM) plays an important role in the progression of cancer. Collagen is the most abundant component in ECM, and it is involved in the biological formation of cancer. Although type XI collagen is a minor fibrillar collagen, collagen XI alpha 1 chain (COL11A1) has been found to be upregulated in a variety of cancers including ovarian cancer, breast cancer, thyroid cancer, pancreatic cancer, non-small-cell lung cancer, and transitional cell carcinoma of the bladder. High levels of COL11A1 usually predict poor prognosis, while COL11A1 is related to angiogenesis, invasion, and drug resistance of cancer. However, little is known about the specific mechanism by which COL11A1 regulates tumor progression. Here, we have organized and summarized the recent developments regarding elucidation of the relationship between COL11A1 and various cancers, as well as the interaction between COL11A1 and intracellular signaling pathways. In addition, we have selected therapeutic agents targeting COL11A1. All these indicate the possibility of using COL11A1 as a target for cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据